Unicentric Comparing Study of Suction Curettage With Standard BOTOX Injection in the Treatment of Patients With Essential Axillar Hyperhidrosis: Comparing of Efficacy, Duration of Effectiveness, and Adverse Events.

Inclusion Criteria: * 18 to 75 years * Persistent bilateral primary axillary hyperhidrosis * Hidrosis interferes with daily activities of patient * Gravimetrically minimal 50 mg spontaneous sweat production in each axilla, measured during 5 minutes in room temperature in calm condition * signed informed consent * patient can and shall continue the trial until the end, and will follow the instructions correcly * women in reproductive period had a pregnancy test Exclusion Criteria: * Medical condition that can be dangerous by treatment with BOTOX, including myastenia gravis, Lambert-Eaton syndrome, ALS, and each other disease that can interfere with the neuromuscular function * Secundary hyperhidrosis (for example secundary on hyperthyroid problems, lymfoma, malaria) * Known allergy against study medication, his components, local anesthesia or iodium * Use of aminoglycosids, curare-like products, or other products which can interfere with the neuromuscular function during the study * Use of therapy for hyperhidrosis with Aluminium chlorid during the study * Infection or skin disease in the area to treat * Participation in an other therapeutic study on the same time * Botuline toxine treatment in the last 4 months * Women who can or who want to become pregnant * Women in reproductive period who don't use the appropriate contraception * Patients in a situation of which the researchers decide it can be dangerous, or can interfere with the study